Franklin Biotechnology c share

204.35 18.97%

Prev Close:
YTD Return*:

2.05B N/A

Net Assets*:
Yield*:

* As of 31-May-15

Quotes delayed, except where indicated otherwise. Currency in USD.

The broker you select will become the default broker for Trade Now

Fund Basics

Morningstar Overall Rating: Total Assets: 2.05B Health 1.10%

Category:
Annual Report Expense Ratio (net):

Performance & Risk

YTD Return: 18.97% 5y Avg Return: 34.90% Rank in Category (ytd): 17 % Rank in Category (ytd): 12.98% Beta (3y): 0.71 Morningstar Risk Rating: 4

Fund Summary

The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. It predominantly invests in equity securities, primarily common stock. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of foreign or U.S. issuer. It is non-diversified. View More